Literature DB >> 17083010

Vaccine prevention of meningococcal disease: making slow progress.

Lee H Harrison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083010     DOI: 10.1086/508780

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

Review 1.  Meningococcal glycoconjugate vaccines.

Authors:  Roberto Gasparini; Donatella Panatto
Journal:  Hum Vaccin       Date:  2011-02-01

2.  Acute bacterial meningitis cases diagnosed by culture and PCR in a children's hospital throughout a 9-Year period (2000-2008) in Athens, Greece.

Authors:  Konstantina Papavasileiou; Eleni Papavasileiou; Georgina Tzanakaki; Aliki Voyatzi; Jenny Kremastinou; Stylianos Chatzipanagiotou
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

3.  Immunogenicity, reactogenicity, and safety of a P1.7b,4 strain-specific serogroup B meningococcal vaccine given to preteens.

Authors:  Jamie Hosking; Kumanan Rasanathan; Florina Chan Mow; Catherine Jackson; Diana Martin; Jane O'Hallahan; Philipp Oster; Ellen Ypma; Stewart Reid; Ingeborg Aaberge; Sue Crengle; Joanna Stewart; Diana Lennon
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

4.  LOS oligosaccharide modification enhances dendritic cell responses to meningococcal native outer membrane vesicles expressing a non-toxic lipid A.

Authors:  Hannah E Jones; Alastair Copland; Hendrik Jan Hamstra; Jonathan Cohen; Jeremy Brown; Nigel Klein; Peter van der Ley; Garth Dixon
Journal:  Cell Microbiol       Date:  2013-11-06       Impact factor: 3.715

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.